No Data
China Development Stock Report for the Third Quarter of 2024
Beihai Gofar Chuanshan Biological (600538.SH) announced the performance for the first three quarters, with a net loss of 20.88 million yuan.
Beihai Gofar Chuanshan Biological (600538.SH) disclosed the third quarter report for 2024, and the company achieved operating income in the first three quarters...
Beihai Gofar Chuanshan Biological (600538.SH): The net loss in the first three quarters was 20.8826 million yuan.
On October 29, beihai gofar chuanshan biological (600538.SH) announced that in the first three quarters of 2024, revenue reached 0.263 billion yuan, a decrease of 6.99% year-on-year; the net income attributable to shareholders of the listed company was -20.8826 million yuan, with a basic EPS of -0.04 yuan.
Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected
Beihai Gofar Chuanshan Biological Chairman Resigns
Director and President Pan Libin of Beihai Gofar Chuanshan Biological (600538.SH) has resigned.
beihai gofar chuanshan biological (600538.SH) announced that the board of directors received the company's...
There's Reason For Concern Over Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Massive 26% Price Jump
